NEW YORK (GenomeWeb) – Eureka Genomics today announced an agreement with animal health firm Zoetis for use of Eureka's next-generation genotyping technology in its products.

Zoetis will use Eureka's technology — which combines high-throughput genetic sequencing and proprietary DNA processing and computing solutions — for its cattle and sheep genetics business. As part of the deal, Florham Park, NJ-based Zoetis has obtained the rights to incorporate the technology into existing and new products. It also has options to distribute products already developed by Eureka.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.